BioCentury
ARTICLE | Finance

Q is for quiet

Investors look for cancer immunotherapy combination, gene therapy data in 2Q15

April 6, 2015 7:00 AM UTC

Investors expect 2Q15 to be fairly quiet in terms of news flow until the deluge of data for cancer immunotherapy combinations come out in June at the American Society of Clinical Oncology meeting. The problem most investors have, however, is that with so many combinations being tested, it is too early to identify which will be of interest.

None of the 11 buysiders contacted by BioCentury mentioned any of the at least nine PDUFA milestones as a major event they were anticipating. ...